These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 14008030)

  • 1. [Influence of prolonged fasting on the clearing activity of post-heparin blood of rabbits].
    WOLFF R; BRIGNON JJ; SCHEMBERG M
    C R Seances Soc Biol Fil; 1962; 156():135-7. PubMed ID: 14008030
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clearing factor in a rat's plasma after 7 days of fasting].
    Póvoa H; Callado AN
    Hospital (Rio J); 1967 Aug; 72(2):455-7. PubMed ID: 5302544
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.
    De Vries R; Wolffenbuttel BH; Sluiter WJ; van Tol A; Dullaart RP
    Clin Lab; 2005; 51(7-8):403-9. PubMed ID: 16122151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The determination of lipoprotein-lipase in post-heparin plasma in man].
    WOLFF R; BRIGNON JJ; SCHEMBERGM
    C R Seances Soc Biol Fil; 1961; 155():575-7. PubMed ID: 14008034
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preheparin lipoprotein lipase mass and apolipoproteinC-III ratio helps identify postprandial triglyceride metabolic marker].
    Miyake N; Miyake K; Higurashi H; Ohsaka A
    Rinsho Byori; 2007 Nov; 55(11):1019-24. PubMed ID: 18154034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing.
    Näsström B; Stegmayr B; Gupta J; Olivecrona G; Olivecrona T
    Nephrol Dial Transplant; 2005 Jun; 20(6):1172-9. PubMed ID: 15797889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific regulation of lipoprotein lipase in humans: effects of fasting.
    Ruge T; Svensson M; Eriksson JW; Olivecrona G
    Eur J Clin Invest; 2005 Mar; 35(3):194-200. PubMed ID: 15733074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood clearing factor in infectious hepatitis].
    Malygina-Dudarova SI; Latsinik GE
    Sov Med; 1969 Apr; 32(4):51-3. PubMed ID: 5378879
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of lipoprotein lipase activity in post heparin plasma of streptozotocin-induced diabetic rats by high-performance liquid chromatography with fluorescence detection.
    Chou YC; Tsai YC; Chen CM; Chen SM; Lee JA
    Biomed Chromatogr; 2008 May; 22(5):502-10. PubMed ID: 18205134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of vitamin B12 on the blood clearing factor and heparin in atherosclerotic patients].
    STEPANOVA MP
    Ter Arkh; 1962 Dec; 34():48-52. PubMed ID: 13983862
    [No Abstract]   [Full Text] [Related]  

  • 11. [An improved determination of the clearing power of the plasma].
    PARAMELLE B; POTOCKI B; SAVIER A
    J Physiol (Paris); 1961; 53():438-9. PubMed ID: 13732733
    [No Abstract]   [Full Text] [Related]  

  • 12. [The clearing factor in relation to the diagnosis and treatment of the atheromasic process].
    ANDREINI A
    G Gerontol; 1960 Aug; 8():559-63. PubMed ID: 13683414
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clearing factor in rheumatic diseases].
    ANDREINI A; VOLTERRANI MT
    Reumatismo; 1959; 11():221-6. PubMed ID: 13793554
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship of lipoprotein lipase and hepatic triacylglycerol lipase activity to serum adiponectin levels in Japanese hyperlipidemic men.
    Kobayashi J; Kusunoki M; Murase Y; Kawashiri M; Higashikata T; Miwa K; Katsuda S; Takata M; Asano A; Nohara A; Inazu A; Mabuchi H
    Horm Metab Res; 2005 Aug; 37(8):505-9. PubMed ID: 16138264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clearing-factor in obese patients.
    Rodrigues J; Povoa H; Povoa LC
    Acta Biol Med Ger; 1967; 19(2):331-2. PubMed ID: 5591570
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
    Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
    Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethazone and clearing factor.
    Povoa H; Calado AN
    Acta Physiol Lat Am; 1967; 17(4):326-7. PubMed ID: 5616578
    [No Abstract]   [Full Text] [Related]  

  • 18. Extreme hypertriglyceridemia following intravenous heparin infusion.
    Al Riyami NB; Frohlich J
    Clin Biochem; 2008 Jul; 41(10-11):907-9. PubMed ID: 18454939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the mechanism of action of heparin or the heparin-clearing factor in fat utilization].
    ZOLLNER N
    Bibl Haematol; 1963; 15():45-58. PubMed ID: 14003901
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of trauma on plasma elimination of exogenous fat and on lipoprotein lipase activity and mass.
    Thörne A; Aberg W; Carneheim C; Olivecrona T; Nordenström J
    Clin Nutr; 2005 Feb; 24(1):66-74. PubMed ID: 15681103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.